HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jun Xie Selected Research

Ethionine

12/2021Ethionine-mediated reduction of S-adenosylmethionine is responsible for the neural tube defects in the developing mouse embryo-mediated m6A modification and is involved in neural tube defects via modulating Wnt/β-catenin signaling pathway.
10/2020Excessive apoptosis and ROS induced by ethionine affect neural cell viability and differentiation.
1/2020Ethionine Suppresses Mitochondria Autophagy and Induces Apoptosis via Activation of Reactive Oxygen Species in Neural Tube Defects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jun Xie Research Topics

Disease

110Neoplasms (Cancer)
11/2022 - 11/2005
40Inflammation (Inflammations)
07/2022 - 06/2010
24Infections
11/2021 - 07/2010
21Myocardial Infarction
01/2021 - 08/2012
18Fibrosis (Cirrhosis)
01/2022 - 05/2009
16Neoplasm Metastasis (Metastasis)
01/2022 - 07/2007
12Rheumatoid Arthritis
05/2021 - 12/2009
12Prostatic Neoplasms (Prostate Cancer)
01/2021 - 11/2005
11Ischemia
06/2021 - 08/2003
10Melanoma (Melanoma, Malignant)
01/2022 - 10/2012
9Body Weight (Weight, Body)
10/2022 - 04/2007
9Carcinogenesis
02/2022 - 11/2008
9Neural Tube Defects (Exencephaly)
12/2021 - 01/2008
9Hyperthermia
12/2021 - 06/2014
9Osteoporosis
07/2021 - 01/2019
8Hypertension (High Blood Pressure)
10/2022 - 02/2012
8Hepatocellular Carcinoma (Hepatoma)
10/2021 - 10/2010
8Infarction (Infarctions)
10/2021 - 06/2005
8Mitochondrial Diseases (Mitochondrial Disease)
10/2021 - 01/2005
8Thrombosis (Thrombus)
09/2021 - 01/2014
8Heart Failure
11/2020 - 01/2011
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 11/2015
7Atherosclerosis
01/2022 - 05/2017
7Peripheral Nervous System Diseases (PNS Diseases)
12/2021 - 01/2019
7Alzheimer Disease (Alzheimer's Disease)
01/2019 - 02/2004
6Necrosis
12/2021 - 10/2012
6Uterine Cervical Neoplasms (Cancer of the Cervix)
10/2021 - 01/2009
6Hypoxia (Hypoxemia)
01/2021 - 01/2014
6Weight Gain
02/2018 - 05/2012
5Colorectal Neoplasms (Colorectal Cancer)
04/2022 - 11/2008
5Carcinoma (Carcinomatosis)
02/2022 - 01/2008
5Myocardial Ischemia (Ischemic Heart Diseases)
01/2022 - 05/2011
5Asthma (Bronchial Asthma)
09/2021 - 01/2005
5Glioma (Gliomas)
07/2021 - 09/2009
5Respiratory Syncytial Virus Infections
01/2021 - 09/2015
5Urinary Bladder Neoplasms (Bladder Cancer)
01/2021 - 01/2008
5Atrial Fibrillation
03/2019 - 01/2015
4Stomach Neoplasms (Stomach Cancer)
06/2022 - 01/2021
4Lung Neoplasms (Lung Cancer)
04/2022 - 01/2015
4COVID-19
03/2022 - 08/2020
4Pain (Aches)
02/2022 - 01/2017
4Reperfusion Injury
01/2022 - 08/2003
4Osteoarthritis
02/2021 - 04/2010

Drug/Important Bio-Agent (IBA)

49Proteins (Proteins, Gene)FDA Link
10/2022 - 07/2004
18Pharmaceutical PreparationsIBA
11/2022 - 02/2011
16Biological ProductsIBA
04/2022 - 11/2005
15Messenger RNA (mRNA)IBA
10/2021 - 03/2010
12MicroRNAs (MicroRNA)IBA
10/2022 - 03/2012
11RNA (Ribonucleic Acid)IBA
06/2022 - 09/2007
10CytokinesIBA
04/2022 - 04/2010
10Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2008
10Small Interfering RNA (siRNA)IBA
01/2021 - 05/2008
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2022 - 12/2007
9CollagenIBA
07/2022 - 08/2012
9Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 01/2019
9Long Noncoding RNAIBA
01/2022 - 04/2017
9Glucose (Dextrose)FDA LinkGeneric
01/2021 - 01/2006
8NAD (NADH)IBA
12/2021 - 09/2015
8Therapeutic UsesIBA
12/2021 - 01/2017
8EnzymesIBA
11/2021 - 11/2008
8Caspase 3 (Caspase-3)IBA
09/2019 - 01/2005
7Syndecan-4IBA
01/2022 - 08/2012
71-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2022 - 06/2020
6Peptides (Polypeptides)IBA
01/2021 - 04/2017
6Amyloid beta-PeptidesIBA
01/2019 - 02/2004
5Chalcone (Benzalacetophenone)IBA
02/2022 - 11/2008
5AntigensIBA
01/2022 - 12/2017
5Blood Glucose (Blood Sugar)IBA
12/2021 - 05/2018
5Phosphotransferases (Kinase)IBA
11/2021 - 11/2008
5AntioxidantsIBA
03/2021 - 02/2011
5DNA (Deoxyribonucleic Acid)IBA
12/2020 - 06/2010
5Doxorubicin (Adriamycin)FDA LinkGeneric
05/2020 - 01/2014
5AntibodiesIBA
05/2020 - 06/2015
5NF-kappa B (NF-kB)IBA
01/2013 - 08/2003
4LipopolysaccharidesIBA
07/2022 - 02/2019
42- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA
06/2022 - 01/2016
4SurvivinIBA
02/2022 - 03/2017
4GoldIBA
01/2022 - 12/2017
4LipidsIBA
01/2022 - 02/2015
4HydrogelsIBA
01/2022 - 11/2020
4epidithiodiketopiperazineIBA
12/2021 - 12/2016
4QuercetinIBA
12/2021 - 04/2020
4InterleukinsIBA
12/2021 - 06/2005
4Interleukin-6 (Interleukin 6)IBA
12/2021 - 01/2017
4CateninsIBA
12/2021 - 01/2021
4GlucocorticoidsIBA
11/2021 - 12/2017
4Ganciclovir (Cytovene)FDA LinkGeneric
11/2021 - 01/2014
4Cisplatin (Platino)FDA LinkGeneric
10/2021 - 01/2017
4GemcitabineFDA Link
07/2021 - 01/2010

Therapy/Procedure

48Therapeutics
06/2022 - 12/2002
12Drug Therapy (Chemotherapy)
04/2022 - 01/2013
10Immunotherapy
06/2022 - 12/2017
9Transplantation
10/2021 - 11/2013
8Precision Medicine
03/2021 - 11/2014
6Injections
10/2022 - 10/2016
5Radiotherapy
11/2021 - 03/2013
5Percutaneous Coronary Intervention
01/2021 - 06/2016
4Knee Replacement Arthroplasty (Total Knee Replacement)
02/2022 - 01/2019
4Photochemotherapy (Photodynamic Therapy)
01/2022 - 01/2020
4Lasers (Laser)
12/2021 - 03/2018